DTIL today
$8.04-$1.11 (-12.13%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns down below $6.64
Key levels
Resistance$10.43
Resistance$9.34
Support$7.82
Support$6.64
Latest news & SEC filings
EarningsPBGENE-HBV clears early-stage trial hurdle; Q3 2026 results also out
DealPrecision BioSciences to Raise $125 Million in Stock Sale
All DTIL news →About Precision BioSciences
Precision BioSciences is a clinical-stage gene editing company built around its proprietary ARCUS platform, which uses a single-component nuclease to make targeted edits such as gene insertion, elimination, and excision. Its wholly owned programs include PBGENE-HBV for chronic hepatitis B and PBGENE-DMD for Duchenne muscular dystrophy, along with a paused mitochondrial disease program. The company also licenses ARCUS to partners including iECURE, Caribou Biosciences, TG Therapeutics, and Imugene, and operates primarily in the United States with clinical trial sites in several other countries.
Based on the company's 10-K filed Mar 12, 2026.
Nasdaq · Healthcare
PRECISION BIOSCIENCES INC (DTIL)
What Is the Price Target for DTIL?
SEPT Low Target
$20.00
SEPT Mid Target
$40.00
SEPT High Target
$60.00
Analyst Consensus
$40.00
Is DTIL a Buy or Sell Right Now?
Thesis
- •Revenue growing -50.1% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DTIL.
Start Free Trial →Is DTIL Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$31.12
20
Moat Score
NONE
2/9
Piotroski Score
-4.0
Altman Z-Score
What Is Smart Money Doing with DTIL?
Insider Signal
SELLING
3 buys / 8 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Frankel Stanley | director | Buy | 1,000 | $6K | Sep 28, 2026 |
| Brown Melinda | director | Buy | 1,135 | $7K | Sep 25, 2026 |
| Germano Geno J | director | Buy | 2,609 | $16K | Sep 25, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →DTIL Growth Story
Revenue YoY
-50.1%
3yr Revenue CAGR
10.9%
EPS Growth YoY
-442.31%
FCF Growth YoY
-12.3%
Revenue Trend
STRONG
Dark Pool Trades for DTIL
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for DTIL, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:12:00 | $8.02 | 1,000 | $$8K | SELL |
| 20:58:50 | $8.05 | 7,500 | $$60K | BUY |
| 20:58:16 | $8.02 | 1,000 | $$8K | BUY |
| 20:57:32 | $8.03 | 1,000 | $$8K | BUY |
| 20:52:48 | $8.10 | 1,000 | $$8K | SELL |
5 dark pool trades shown · $$93K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for PRECISION BIOSCIENCES INC (DTIL) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →DTIL — frequently asked questions
What is DTIL stock price today?
PRECISION BIOSCIENCES INC (DTIL) is at $8.04, down 12.13% (-$1.11) at the Nov 12, 2026 close.
Why is DTIL stock moving today?
Latest DTIL news — Nov 9, 2026: PBGENE-HBV clears early-stage trial hurdle; Q3 2026 results also out · Nov 6, 2026: Precision BioSciences to Raise $125 Million in Stock Sale
What is the DTIL price target?
The average analyst price target for DTIL is $40.00, ranging from $20 to $60, based on 2 analysts.
What do analysts rate DTIL?
Analyst ratings for DTIL: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did DTIL beat earnings?
DTIL last reported on Aug 6, 2026: EPS -$1.26 vs -$0.80 expected — a miss of 56.7%.
Does DTIL pay a dividend?
DTIL does not currently pay a dividend.
What are DTIL support and resistance levels?
Support: $7.82, $6.64, $5.72. Resistance: $9.34, $10.43, $11.29.
What are insiders doing with DTIL?
Insider activity: SELLING, 3 buys and 8 sells in the last 90 days.
What is the latest news on DTIL?
Nov 9, 2026: PBGENE-HBV clears early-stage trial hurdle; Q3 2026 results also out · Nov 6, 2026: Precision BioSciences to Raise $125 Million in Stock Sale